US health insurer Humana has agreed to sell its stake in home health and hospice provider Gentiva for approximately $900 million (£710 million), according to company statements. The transaction, expected to close later this year, marks a significant shift in Humana's portfolio as it moves to concentrate on its core Medicare Advantage and insurance offerings.
Gentiva, which serves over 200,000 patients annually across the United States, was acquired by Humana in 2021 as part of a push into integrated care delivery. However, rising costs and regulatory pressures in the home-health sector have prompted the insurer to exit the business. Analysts at Jefferies noted that the sale could improve Humana's balance sheet and free up capital for share buybacks or acquisitions.
For UK investors, the deal has limited direct impact on London-listed equities, but it does highlight a broader trend among global healthcare firms reassessing vertical integration strategies. The FTSE 100 was trading flat on the day of the announcement, with the healthcare sector index dipping 0.3 per cent as investors weighed mixed signals from US markets. Shares of UK-listed home-care providers such as Mears Group and CareTech Holdings saw little movement, as the Gentiva sale is seen as a US-specific event.
Market commentators pointed out that the transaction reflects a wider recalibration in the healthcare industry, where firms are pulling back from expensive acquisitions made during the pandemic. 'This is a clear signal that the era of aggressive vertical integration in US healthcare may be cooling,' said Sarah Thompson, a healthcare analyst at Shore Capital. 'For UK pension funds with exposure to US healthcare stocks, this could mean a period of reduced volatility as companies refocus on profitability.'
The sale price of $900 million represents a modest premium over Gentiva's book value, though terms were not fully disclosed. Humana stated it expects to use the proceeds to reduce debt and invest in its core insurance business. No UK regulatory approvals are required, as the transaction is purely domestic to the United States.